Virus News and Research

Latest Virus News and Research

New HIV drug that is like a "Swiss Army knife of immunotherapies"

HIV is a tricky virus that causes a unique phenomenon where the virus hides within the immune cells of patients when they are on treatment with the antiretroviral therapy (ART) drugs. When they are off the drugs, the virus comes back.

7 Apr 2019

Heart and lung transplants from hepatitis-C infected donors considered safe

A recent trial has shown that heart and lungs from donors infected with hepatitis C can be safely transplanted, without recipients becoming infected with the virus.

5 Apr 2019

Researchers determine atomic structure of fusion protein of a prokaryotic organism

Many viruses, including that perennial winter affliction, the influenza virus, are protected by a lipid membrane on loan from the host cell.

5 Apr 2019

Timed vaginal insemination can be safe, effective way to help HIV-affected couples conceive

Women with HIV were once advised against having children for fear that the infection could be passed on to their babies.

5 Apr 2019

Scientists solve mystery of how bacterial nanowires conduct electricity

Scientists have made a surprising discovery about how strange bacteria that live in soil and sediment can conduct electricity.

5 Apr 2019

New class of molecules could someday become basis for Zika-specific therapeutic

The Zika virus is widely known for causing microcephaly and other brain defects in the fetuses of pregnant, infected women.

4 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

Infectious diseases experts and transplant physicians and surgeons at Brigham and Women's Hospital have blocked the transmission of hepatitis C from infected organ donors to recipients in need of hearts or lungs.

4 Apr 2019

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

In a first on the quest to cure HIV, University of Pittsburgh Graduate School of Public Health scientists report today in EBioMedicine that they've developed an all-in-one immunotherapy approach that not only kicks HIV out of hiding in the immune system, but also kills it.

4 Apr 2019

Rate of HPV infection high among sexual minority men despite availability of vaccine

The rate of human papillomavirus infection is high among young minority gay, bisexual, and other men who have sex with men despite the availability of a vaccine that can prevent the infection, a Rutgers School of Public Health study found.

4 Apr 2019

Cervical cancer mortality rate found to be higher among older women

Denmark has one of highest incidences of cervical cancer in the Western world. But once a person has turned 65, they are no longer automatically screened - even though older women are in fact those who have the highest mortality.

3 Apr 2019

New ebolavirus species found in bats may be more common than previously thought

A recently discovered species of ebolavirus may be more widespread than previously thought and could be hosted by a particular bat species, according to findings published by a University of Arkansas biologist. The ebolavirus species, named Bombali, is one of two currently not known to infect humans.

2 Apr 2019

European surveillance data shows slight decrease in newly reported hepatitis C cases

European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31 000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area.

2 Apr 2019

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Human immunodeficiency virus, or HIV, attacks the immune system, making affected individuals more susceptible to infections. When patients with HIV are treated with antiretroviral therapy, their immune system can recover, but some of them produce self-destructive proteins, or autoantibodies.

2 Apr 2019

Government's refusal to offer HPV catch-up vaccinations to older boys is discriminatory, says health economist

Professor Giampiero Favato is a health economist and director of doctoral programmes at Kingston University's Business School.

1 Apr 2019

Neuroscientists develop new model to trial preventative treatments for schizophrenia

Neuroscientists at The University of Queensland have developed a new animal model of schizophrenia that will enable researchers around the world to better understand the disease and develop new treatments.

30 Mar 2019

WHO guidelines for chronic hepatitis B fail to detect half of the patients in Ethiopia needing treatment

Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier.

29 Mar 2019

Researchers discover 'taste bud cells' in mice lungs after severe bout of flu

Most people who weather an infection with influenza fully recover after a week or two. But for some, a severe case of the flu can actually reshape the architecture of their lungs and forever compromise their respiratory function.

29 Mar 2019

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.

29 Mar 2019

Study uncovers details about human immune response to dengue infection

About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection and a close "cousin" of the Zika virus - and yet, no effective treatment or safe licensed vaccine exists.

29 Mar 2019

Virus News and Research

Latest Virus News and Research

New HIV drug that is like a "Swiss Army knife of immunotherapies"

Heart and lung transplants from hepatitis-C infected donors considered safe

Researchers determine atomic structure of fusion protein of a prokaryotic organism

Timed vaginal insemination can be safe, effective way to help HIV-affected couples conceive

Scientists solve mystery of how bacterial nanowires conduct electricity

New class of molecules could someday become basis for Zika-specific therapeutic

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

Hepatitis C-infected thoracic organs can be safely transplanted, study finds

New all-in-one immunotherapy approach kicks out hiding HIV and also kills it

Rate of HPV infection high among sexual minority men despite availability of vaccine

Cervical cancer mortality rate found to be higher among older women

New ebolavirus species found in bats may be more common than previously thought

European surveillance data shows slight decrease in newly reported hepatitis C cases

MUSC study provides evidence for link between 'leaky gut' and autoantibody production in HIV-positive patients

Government's refusal to offer HPV catch-up vaccinations to older boys is discriminatory, says health economist

Neuroscientists develop new model to trial preventative treatments for schizophrenia

WHO guidelines for chronic hepatitis B fail to detect half of the patients in Ethiopia needing treatment

Researchers discover 'taste bud cells' in mice lungs after severe bout of flu

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

Study uncovers details about human immune response to dengue infection

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Newsletters you may be interested in